The annual product quality review procedure was inadequate.
Inspection Record
Canadian Hospital Specialties Ltd — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The importer and/or the distributor's compliance with the current master production documents and/or the marketing authorization was inadequate. The assessment to release finished products was inadequate.
The ongoing stability program for a drug was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2026-09-16. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
